Epstein-Barr Virus Infection research hub

Individualized Treatment Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

This study looks at new ways to treat nasopharyngeal cancer, a type of head and neck cancer. It focuses on using a blood test for the Epstein-Barr virus (EBV) to decide the best treatment after initial therapy. We want to see if different drug combinations improve outcomes.